In the height of summer, now is the time to forge ahead, uniting our strengths to usher in a new future. On July 11, 2026, Chongqing Aolong Biological Products Co., Ltd. held its first company-wide meeting for the first half of 2026—the “United Hearts, Far-reaching Vision; United Strengths, Forging Ahead”—in the grand conference room on the third floor of the company’s administrative center. This gathering marked the first all‑staff meeting since Hengtong Shares completed its merger and restructuring of Aolong Biological. It served not only as a retrospective review of past achievements and lessons learned but also as a rallying call to align thinking, consolidate collective efforts, map out strategic plans, and press forward with renewed vigor—making it a milestone event for deepening post‑merger integration, strengthening the company’s operational foundation, accelerating progress toward annual targets, and embarking on a new journey of high‑quality development.

▲Scene from the conference venue

Li Haijiang, President of Zhejiang Hengtong Holding Co., Ltd. and Chairman of Chongqing Aolong Biological Products Co., Ltd., Xie Jianyong, Chairman and President of Huapai Biotechnology Group, and Fu Gang, Vice President of Huapai Biotechnology Group and General Manager of Chongqing Aolong Biological Products Co., Ltd., attended the meeting and delivered important speeches. Wang Bo, Director of the President’s Office of Zhejiang Hengtong Holding Co., Ltd., along with Gong Wenbo and Qi Guangyu, Assistants to the Chairman of Huapai Biotechnology Group, and more than 200 mid‑level and senior managers as well as all employees of Chongqing Aolong Biological Products Co., Ltd., gathered on site to discuss development and jointly usher in a new chapter.

▲All attendees rose to their feet and sang in unison the three corporate anthems: “We Are the Essence,” “Forge Ahead with HuaPai,” and “The Song of Hengtong.”

The conference officially kicked off to the rousing and inspiring sounds of the company’s anthems. All employees sang in unison three corporate theme songs—“We Are the Essence,” “Bravely Marching Forward with Huapai,” and “The Song of Hengtong.” The powerful, resonant melodies recalled the company’s journey of struggle and carried forward its enduring spirit, vividly showcasing the Aolong team’s ethos of striving for progress, daring to take on challenges, and stepping up with practical action. This further united all employees in a shared vision and purpose, forging an immense force of solidarity and collaboration, and injecting a vigorous, forward‑moving spirit into the company’s new phase of development.

▲ Fu Gang, General Manager of Aolong Bio, presented to the conference a business management report for the first half of 2026, titled “Unite as One, Strive Far; Pool Our Strengths and Forge Ahead.”

At the meeting, Fu Gang, General Manager of Chongqing Aolong Biological Products Co., Ltd., presented the 2026 First-Half-Year Business and Management Report, titled “Unite as One to Reach Far, Pool Strength to Move Forward.” Grounded in the broader trends of the animal health industry and the company’s overall strategic vision, the report comprehensively reviewed the company’s performance across key areas—including R&D and production, marketing, quality control, internal management, and international trade expansion—during the first half of the year. It also provided an objective analysis of the current industry landscape, existing shortcomings, and emerging opportunities, while clearly defining the priorities for the second half and detailing specific tasks for each business segment. In addition, he encouraged all employees to remain committed to a pragmatic, results‑oriented approach, to unite their efforts, confront challenges head‑on, and strive with full dedication to achieve the year’s goals.

Fu Gang pointed out that the domestic animal health industry is currently undergoing a critical phase of transformation—characterized by stringent regulatory oversight, market restructuring, upgrading of farming practices, and industry consolidation. The sector is steadily advancing toward standardization, professionalization, intensification, and high-end development, as the old growth model based on extensive operations and homogeneous competition can no longer meet the demands of the new era. Only by adhering to innovation-driven strategies, prioritizing quality, breaking into new markets, and embracing open‑door development can enterprises navigate this period of change with stability and sustainability, seizing the initiative.

With regard to the company’s operations and development in the second half of the year, Fu Gang has laid out a systematic plan for each major business segment: In the R&D and manufacturing segment, the focus will be on accelerating project acceptance, expediting regulatory‑compliance filings, and upgrading hardware capabilities; continuously optimizing production processes, expanding the product pipeline, and elevating quality‑control standards to solidify the company’s core foundation for innovation and technological advancement. For the cattle and sheep segment, the priority is to capitalize on the momentum of large‑scale farming upgrades, refine product‑portfolio solutions, strengthen market penetration of flagship offerings, and further consolidate brand leadership in niche markets. In the government‑procurement segment, the strategy will remain one of steady growth with enhanced quality, addressing gaps and reinforcing strengths, while leveraging professional services, superior product quality, and a strong reputation to steadily increase market share in the public‑sector procurement space. The swine‑breeding segment will center on lean management, cost reduction, and efficiency gains, deepening engagement with strategic key accounts and meticulously cultivating existing customer relationships, thereby building momentum for a breakthrough in 2027. Meanwhile, the international‑trade segment will leverage the advantages of the Belt and Road Initiative, accelerate overseas product registration and global‑standard certifications, and steadily pursue breakthroughs in priority target markets, forging a multi‑dimensional, integrated internationalization framework that combines “product export, technology transfer, and localized operations.”

Subsequently, Xie Jianyong, Chairman and President of Huapai Biotechnology Group, delivered a guiding address. He fully commended the phased achievements attained by Aolong Bio in the first half of the year—namely, stable operations, market expansion, strengthened management, and accelerated development—and expressed his heartfelt gratitude to all employees for their steadfast dedication and hard work.

▲ Xie Jianyong, Chairman and President of Huapai Biotechnology Group, delivered a guiding address.

Xie Jianyong emphasized that, while acknowledging past achievements, all employees must maintain a clear strategic awareness, squarely confront development gaps, break free from path dependencies, and abandon conservative mindsets, steadfastly pursuing a development path characterized by market orientation, professionalization, and high‑quality excellence. In the face of intense industry competition and a complex market environment, the company must concentrate its superior resources on tackling core growth areas, with particular focus on breakthroughs in key domains such as developing large corporate clients, implementing differentiated market strategies, and expanding overseas distribution channels. At the same time, leveraging the dual strengths of Huapai’s deep technological expertise and industrial platform, combined with Hengtong’s capital strength and extensive channel networks, the company will build a comprehensive, end‑to‑end professional service system spanning pre‑sale, in‑sale, and post‑sale phases, continuously cultivating new sources of profit growth.

Xie Jianyong urged the company to take this merger and restructuring as a fresh starting point for development, to formulate its strategic plan for the next three to five years from a high-level perspective, clearly define its long-term growth trajectory, and refine its phased objectives. He emphasized adhering to a strategy of driving market breakthroughs through product‑level innovation and achieving comprehensive advancement by elevating key business segments, while continuously strengthening its product portfolio, enhancing its brand, and expanding its industry footprint, thereby forging a new chapter of high‑quality development for Aolong Bio.

At the conference, Li Haijiang, President of Zhejiang Hengtong Holding Co., Ltd. and Chairman of Aolong Bio, delivered a keynote address titled “Unite Hearts and Minds to Embark on a New Journey; Join Hands to Write a New Chapter.” He profoundly elucidated the far-reaching strategic significance of this merger and restructuring, emphasizing that this collaboration is not merely a change in equity but rather a strategic initiative by Hengtong Holding and Huapai Bio—grounded in industry trends, oriented toward the long-term future, and designed to achieve a powerful alliance and complementary strengths. He further underscored that this partnership represents a major historical opportunity for Aolong Bio to break through developmental bottlenecks, pursue iterative upgrades, and advance to a higher level of growth.

▲ Li Haijiang, President of Zhejiang Hengtong Holding Co., Ltd. and Chairman of Aolong Bio, delivered a keynote address titled “Unite Hearts and Minds to Embark on a New Journey; Join Hands to Write a New Chapter.”

Li Haijiang pointed out that the animal health industry is witnessing steadily rising concentration, with large-scale, platform‑based, and innovation‑driven development emerging as an inevitable trend. The sector has moved beyond a fragmented, resource‑intensive growth model, and collaborative integration, resource pooling, and win‑win synergy have become the core strategies for enterprises seeking sustainable, long-term success. Following the completion of the merger and acquisition, Aolong Bio will fully inherit Huapai Bio’s mature industrial foundation, robust technological system, and distinguished team culture, while comprehensively adopting Hengtong Holding’s modern management framework, premium industry resources, extensive market channels, and high‑end platform advantages. This will enable seamless resource sharing, complementary capabilities, mutual market penetration, and synergistic team development, thereby opening up a new chapter of high‑quality growth across all dimensions.

Li Haijiang emphasized that, guided by a long-term industrial strategy, Hengtong Holdings will stay firmly aligned with the overarching development trajectory of the “prevention–nutrition–treatment” integrated value chain. The company will prioritize empowering Aolong Bio’s core business in ruminant vaccines for cattle and sheep, while continuously ramping up investment in scientific innovation, market expansion, and internationalization. By doing so, Hengtong aims to drive the enterprise’s transformation and upgrading, striving to establish Aolong Bio as a benchmark player and a leading, well‑known brand in China’s animal health vaccine sub‑sector.

In light of the company’s M&A integration, team cohesion, and future high‑quality development, Li Haijiang articulated five earnest expectations and clear work directives for all cadres and employees of Aolong Company:

I. Elevate our perspective, align our thinking, and proactively embrace change.

All employees must adopt a holistic perspective aligned with the Group’s strategic vision, deeply appreciate the contemporary significance and strategic value of mergers and acquisitions and integration, proactively transcend conventional mindsets, and break free from the constraints of traditional development. With a fresh understanding and a renewed mindset, they should actively adapt to new mechanisms, integrate into new systems, and embrace new transformations—seizing emerging opportunities and cultivating new drivers of growth in the midst of change.

II. Uphold our original aspirations, maintain overall stability, and seek progress while ensuring stability to achieve breakthroughs.

We have consistently adhered to the overarching principle of seeking progress while maintaining stability, firmly safeguarding our core business, our workforce, and our market position, thereby consolidating the foundations for enterprise development. On the premise of upholding the bottom lines of safety, quality, and operational stability, we have proactively embraced change and taken decisive action, achieving higher quality within a stable framework and making steady progress, thus continuously driving sound operations, healthy growth, and iterative advancement.

III. Proactively integrate, embrace inclusiveness, and advance together to deepen integrated development.

We will vigorously promote the Hengtong spirit of “daring to lead, striving for excellence, scaling new heights, and pioneering great undertakings,” adopting an open, inclusive, and collaborative approach to comprehensively advance the integration of management, culture, teams, and business operations. In doing so, we will truly achieve unity of thought, alignment of goals, synchronization of actions, and harmony in development, thereby forging a powerful synergy that drives all employees to work together with determination and momentum.

IV. Embrace pragmatism and responsibility, enhance quality and efficiency, and jointly build a community of shared development.

Taking mergers and restructurings as a fresh starting point, we are comprehensively reshaping our work standards, optimizing management processes, and enhancing the effectiveness of our duties. All employees, grounded in their respective roles, are committed to practical action, relentless pursuit of excellence, and proactive responsibility, ensuring that cost reduction, efficiency gains, quality improvement, and innovation are consistently and effectively implemented. We continue to build a community of shared interests, co‑created, co‑governed, and co‑benefited by both the enterprise and its workforce, so that the fruits of corporate development are distributed more equitably and broadly to every employee, thereby continuously strengthening everyone’s sense of belonging, well‑being, and motivation to contribute and succeed.

V. Deepen our presence overseas, broaden our strategic outlook, and accelerate our international expansion.

Rooted in the domestic market yet with a global outlook, we are deepening cross‑border technology exchanges, co‑building international distribution channels, and strengthening our overseas brand presence—all under an increasingly open vision and a long‑term strategic framework—to steadily expand our footprint in the international marketplace. Backed by robust product capabilities, premium technical services, and proven operational excellence, we are driving corporate transformation and upgrading, elevating quality and achieving breakthroughs, thus embarking on a new chapter of internationalization and high‑quality growth for Aolong Bio.

Uniting new strengths to embark on a new journey, and advancing with unwavering resolve toward the future. The successful convening of this conference has further aligned the entire organization’s vision, clarified our strategic roadmap, reinforced accountability for the year ahead, and boosted team morale—signaling a rallying call for the company to deepen M&A integration, tackle our annual objectives head-on, and achieve leapfrog growth.

In the next phase, all members of the Aolong team will thoroughly implement the spirit of this conference, keep firmly in mind the expectations and instructions of the Group’s leadership, uphold our original commitment to pragmatic action, bravely shoulder the mission of development, and unite as one to forge ahead. With the mutual empowerment and synergistic support of Huapai Bio and Hengtong Holdings, we will deepen our engagement in the animal health‑tech innovation sector, steadfastly adhere to the principle of quality‑driven growth, expand both domestic and international market reach, and accelerate the upgrading of our industrial capabilities. By embracing change to break new ground, driving progress through concrete action, and pooling our strengths to achieve outstanding results, we will strive to write a new chapter of high‑quality development for Aolong Bio!